- Signaling Pathways
- GPCR/G Protein
- Free Fatty Acid Receptor
Free Fatty Acid Receptor
FFAR
Free Fatty Acid Receptor Isoform Specific Products
All Product Categories
-
Free Fatty Acid Receptor Inhibitors
(3)
View all products
-
Free Fatty Acid Receptor Agonists
(87)
View all products
-
Free Fatty Acid Receptor Antagonists
(6)
View all products
-
Free Fatty Acid Receptor Activators
(7)
View all products
-
Free Fatty Acid Receptor Modulators
(3)
View all products
-
Free Fatty Acid Receptor Controls
(3)
View all products
-
Free Fatty Acid Receptor Ligand
(1)
View all products
-
Free Fatty Acid Receptor Related Products (125)
-
Antibodies (4)
-
Free Fatty Acid Receptor Isoform Comparison
-
(±)-Pinocembrin (Standard)
0 ImagesSynonyms: (±)-5,7-Dihydroxyflavanone (Standard); NSC 43318 (Standard)(±)-Pinocembrin (Standard) is the analytical standard of (±)-Pinocembrin. This product is intended for research and analytical applications. (±)-Pinocembrin ((±)-5,7-Dihydroxyflavanone) is a GPR120 ligand able to promote wound healing in HaCaT cell line. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
DC260126 (Standard)
0 ImagesCat. No.: HY-101906RCAS No.: 346692-04-4DC260126 (Standard) is the analytical standard of DC260126 (HY-101906). This product is intended for research and analytical applications. DC260126 is a potent antagonist of GPR40 (FFAR1). DC260126 dose-dependently inhibits GPR40-mediated Ca2+ elevations stimulated by linoleic acid, oleic acid, palmitoleic acid and lauric acid (IC50: 6.28, 5.96, 7.07, 4.58 μM, respectively). DC260126 could protect MIN6 β cells from palmitate-induced ER stress and apoptosis. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
Fezagepras (Standard)
0 ImagesCat. No.: HY-100775ARCAS No.: 1002101-19-0Synonyms: Setogepram (Standard); PBI-4050 (Standard)Fezagepras (Standard) is the analytical standard of Fezagepras. This product is intended for research and analytical applications. Fezagepras (Setogepram) acts as an orally active agonist for GPR40 and as an antagonist or inverse agonist for GPR84. Fezagepras decreases renal, liver and pancreatic fibrosis. Fezagepras exerts anti-fibrotic, anti-inflammatory and anti-proliferative actions. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
TUG-1609
0 ImagesCat. No.: HY-185287CAS No.: 2101952-37-6TUG-1609 is a fluorescent tracer targeting free fatty acid receptor 2 (FFA2/GPR43) with a Kd value of 65.1 nM. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
GPR40 Agonist 2
0 ImagesCat. No.: HY-U00395CAS No.: 1147729-48-3GPR40 Agonist 2 is a GPR40 agonist that can be used in the research of diabetes, extracted from patent WO2009054479A1. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
Your Search Returned No Results.
Sorry. There is currently no product that acts on isoform Bcl-2, Bcl-W and Bim together.Please
try each isoform separately.